Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Edelweiss MSCI India D&W HC 45 Reg Gr
as of 05 Jul 2026, 12:14 PM
Invested Amount
Est. Return
Total Value
rated by Value Research
Your principal will be at Very High Risk
Absolute Returns
CAGR
Company Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | Healthcare | E | 11.25% |
| Eli Lilly and Co | Healthcare | E | 6.01% |
| Max Healthcare Institute Ltd Ordinary Shares | Healthcare | E | 5.73% |
| Apollo Hospitals Enterprise Ltd | Healthcare | E | 5.69% |
| Divi's Laboratories Ltd | Healthcare | E | 5.17% |
| Cipla Ltd | Healthcare | E | 5.14% |
| Dr Reddy's Laboratories Ltd | Healthcare | E | 4.71% |
| Johnson & Johnson | Healthcare | E | 4.25% |
| Lupin Ltd | Healthcare | E | 3.90% |
| Torrent Pharmaceuticals Ltd | Healthcare | E | 3.46% |
| Fortis Healthcare Ltd | Healthcare | E | 3.12% |
| AbbVie Inc | Healthcare | E | 2.91% |
| Laurus Labs Ltd | Healthcare | E | 2.55% |
| Novartis AG ADR | Healthcare | E | 2.28% |
| Glenmark Pharmaceuticals Ltd | Healthcare | E | 2.24% |
| Merck & Co Inc | Healthcare | E | 2.20% |
| Aurobindo Pharma Ltd | Healthcare | E | 2.15% |
| Mankind Pharma Ltd | Healthcare | E | 1.88% |
| Alkem Laboratories Ltd | Healthcare | E | 1.82% |
| Amgen Inc | Healthcare | E | 1.48% |
| Ipca Laboratories Ltd | Healthcare | E | 1.44% |
| Abbott Laboratories | Healthcare | E | 1.42% |
| Biocon Ltd | Healthcare | E | 1.41% |
| Thermo Fisher Scientific Inc | Healthcare | E | 1.37% |
| Gilead Sciences Inc | Healthcare | E | 1.31% |
| Intuitive Surgical Inc | Healthcare | E | 1.27% |
| Zydus Lifesciences Ltd | Healthcare | E | 1.25% |
| Aster DM Healthcare Ltd Ordinary Shares | Healthcare | E | 1.03% |
| Danaher Corp | Healthcare | E | 0.95% |
| Stryker Corp | Healthcare | E | 0.94% |
| Gland Pharma Ltd | Healthcare | E | 0.91% |
| Vertex Pharmaceuticals Inc | Healthcare | E | 0.90% |
| Medtronic PLC | Healthcare | E | 0.89% |
| Narayana Hrudayalaya Ltd | Healthcare | E | 0.88% |
| Ajanta Pharma Ltd | Healthcare | E | 0.88% |
| Novo Nordisk AS ADR | Healthcare | E | 0.86% |
| GlaxoSmithKline Pharmaceuticals Ltd | Healthcare | E | 0.73% |
| Piramal Pharma Ltd | Healthcare | E | 0.63% |
| Global Health Ltd | Healthcare | E | 0.62% |
| Regeneron Pharmaceuticals Inc | Healthcare | E | 0.58% |
| Syngene International Ltd | Healthcare | E | 0.52% |
| Becton Dickinson & Co | Healthcare | E | 0.36% |
| Agilent Technologies Inc | Healthcare | E | 0.24% |
| IQVIA Holdings Inc | Healthcare | E | 0.21% |
| Illumina Inc | Healthcare | E | 0.14% |
| Net Receivables/(Payables) | - | CA | 0.17% |
| Clearing Corporation Of India Ltd. | - | CR | 0.15% |
| Accrued Interest | - | CA | 0.00004% |
Equity / Debt / Cash Split
Equity
99.68%
Cash
0.32%
Equity sector allocation
Healthcare
99.68%
Others
0.32%
Asset Management Company

Nippon India Taiwan Equity Reg Gr
Equity
Min. Investment
₹500
Category Returns
30.10%
63.78%
3Y Returns
+63.78%

DSP Wld Gld Mng Ovrs Eq Omni FoF Gr
Equity
Min. Investment
₹100
Category Returns
30.10%
63.78%
3Y Returns
+45.98%

DSP Wld Gld Mng Ovrs Eq Omni FoF IDCW-R
Equity
Min. Investment
₹100
Category Returns
30.10%
63.78%
3Y Returns
+45.89%
Investment Objective of the Scheme
Key Features of The Fund
5-year return
+13.64%
Fund Manager
Bhavesh Jain
Risk Profile
Very High Risk
Expense Ratio
1.06%
Fund Size
₹174.93 Cr
Edelweiss MSCI India D&W HC 45 Reg Gr is currently priced at ₹20.29, as of 05 Jul 2026, 12:14 PM. The fund has recorded a change of ₹0.15 (0.73%), indicating its recent movement in the market.
Tracking NAV trends helps investors understand short-term price movement, while long-term performance gives a better picture of wealth creation potential.
Edelweiss MSCI India D&W HC 45 Reg Gr is an open-ended mutual fund that invests based on its stated objective and benchmark.
Key details:
Asset Size: ₹174.93 Cr
Expense Ratio: 1.06%
Cash Holding: 0.32%
Plan Type: Dividend
Benchmark: MSCI Ind Dom & Wld HealthC 45 NR INR
Launch Date: 2020-10-26
Exit Load: 0.00
These factors help investors evaluate cost, scale, and fund positioning before making an investment decision.
Edelweiss MSCI India D&W HC 45 Reg Gr has delivered returns across multiple timeframes, reflecting its ability to perform across different market conditions.
Returns:
1 Month: -4.78%
3 Months: -3.89%
6 Months: 1.15%
1 Year: 3.82%
3 Years: 0.75%
5 Years: 0.90%
Short-term returns indicate recent momentum, while long-term returns show consistency and wealth creation ability.
Understanding risk is important before investing. Edelweiss MSCI India D&W HC 45 Reg Gr falls under: For investors in the 20–40 age group, selecting a fund with the right risk level is important based on financial goals, investment horizon, and comfort with market movements.
Risk Level: Very High Risk
The riskometer helps investors understand how stable or volatile the fund can be based on its investment strategy and asset allocation. Funds with higher risk levels may offer better return potential over time, but they can also experience sharper short-term fluctuations. This classification reflects the volatility associated with the fund. Higher risk funds may offer higher returns but come with greater fluctuations.
The asset allocation of Edelweiss MSCI India D&W HC 45 Reg Gr shows how investments are distributed across asset classes.
Equity Allocation: 99.68%
Cash Allocation: 0.32%
This allocation plays a key role in determining the fund’s risk and return profile.
Edelweiss MSCI India D&W HC 45 Reg Gr diversifies its investments across sectors to reduce risk.
Sector Holding Detail
Healthcare: 99.68%
Sector allocation data helps investors understand which industries the fund is focusing on.
Edelweiss MSCI India D&W HC 45 Reg Gr is managed by:
AMC Name: Edelweiss Asset Management Limited
A strong fund house with a proven track record can improve investor confidence.
Investors can start investing in Edelweiss MSCI India D&W HC 45 Reg Gr with:
Minimum Investment: ₹100
This makes the fund accessible for both beginners and experienced investors.
The Edelweiss MSCI India D&W HC 45 Reg Gr has invested the majority of its money in the stocks of the following companies:
| Company | Percentage of Portfolio |
|---|---|
| Sun Pharmaceuticals Industries Ltd | 11.25% |
| Eli Lilly and Co | 6.01% |
| Max Healthcare Institute Ltd Ordinary Shares | 5.73% |
| Apollo Hospitals Enterprise Ltd | 5.69% |
| Divi's Laboratories Ltd | 5.17% |
| Cipla Ltd | 5.14% |
| Dr Reddy's Laboratories Ltd | 4.71% |
| Johnson & Johnson | 4.25% |
| Lupin Ltd | 3.90% |
| Torrent Pharmaceuticals Ltd | 3.46% |
| Fortis Healthcare Ltd | 3.12% |
| AbbVie Inc | 2.91% |
| Laurus Labs Ltd | 2.55% |
| Novartis AG ADR | 2.28% |
| Glenmark Pharmaceuticals Ltd | 2.24% |
| Merck & Co Inc | 2.20% |
| Aurobindo Pharma Ltd | 2.15% |
| Mankind Pharma Ltd | 1.88% |
| Alkem Laboratories Ltd | 1.82% |
| Amgen Inc | 1.48% |
| Ipca Laboratories Ltd | 1.44% |
| Abbott Laboratories | 1.42% |
| Biocon Ltd | 1.41% |
| Thermo Fisher Scientific Inc | 1.37% |
| Gilead Sciences Inc | 1.31% |
| Intuitive Surgical Inc | 1.27% |
| Zydus Lifesciences Ltd | 1.25% |
| Aster DM Healthcare Ltd Ordinary Shares | 1.03% |
| Danaher Corp | 0.95% |
| Stryker Corp | 0.94% |
| Gland Pharma Ltd | 0.91% |
| Vertex Pharmaceuticals Inc | 0.90% |
| Medtronic PLC | 0.89% |
| Narayana Hrudayalaya Ltd | 0.88% |
| Ajanta Pharma Ltd | 0.88% |
| Novo Nordisk AS ADR | 0.86% |
| GlaxoSmithKline Pharmaceuticals Ltd | 0.73% |
| Piramal Pharma Ltd | 0.63% |
| Global Health Ltd | 0.62% |
| Regeneron Pharmaceuticals Inc | 0.58% |
| Syngene International Ltd | 0.52% |
| Becton Dickinson & Co | 0.36% |
| Agilent Technologies Inc | 0.24% |
| IQVIA Holdings Inc | 0.21% |
| Illumina Inc | 0.14% |
| Net Receivables/(Payables) | 0.17% |
| Clearing Corporation Of India Ltd. | 0.15% |
| Accrued Interest | 0.00% |
The Edelweiss MSCI India D&W HC 45 Reg Gr has invested the majority of its money in the stocks of the following sectors -
| Company | Percentage of Portfolio |
|---|---|
| Healthcare | 99.68% |
Investing in mutual funds is easy on HDFC SKY.
Follow these simple steps to invest in Edelweiss MSCI India D&W HC 45 Reg Gr:
By signing up I certify terms, conditions & privacy policy